Characteristic | n | N | % | (95% CI) |
---|---|---|---|---|
Experienced diarrhoea in the past 2Â weeks | ||||
 No | 1,077 | 1,242 | 86.7 | (84.7–88.5) |
 Yes | 165 | 1,242 | 13.3 | (11.5–15.3) |
ART status | ||||
 No | 90 | 1,242 | 7.3 | (5.9–8.8) |
 Yes | 1,152 | 1,242 | 92.8 | (91.2–94.1) |
Duration on ART in years | ||||
  < 1 | 248 | 1,152 | 21.5 | (19.2–24.0) |
 1–2 | 306 | 1,152 | 26.6 | (24.1–29.2) |
 3–4 | 339 | 1,152 | 29.4 | (26.9–32.1) |
 5–6 | 168 | 1,152 | 14.6 | (12.7–16.7) |
  > 6 | 91 | 1,152 | 7.9 | (6.5–9.6) |
  Median (IQR) |  | 1,152 | 3 (1.1–4.3) |  |
ART adherence in the past month | ||||
  < 95% | 83 | 1,139 | 7.3 | (5.9–9.0) |
  ≥ 95% | 1,056 | 1,139 | 92.7 | (91.0–94.1) |
 Missing | 13 | 1,152 | 1.1 | - |
History of TB treatment | ||||
 No | 894 | 1,238 | 72.2 | (69.6–74.6) |
 Yes | 344 | 1,238 | 27.8 | (25.4–30.4) |
 Missing | 4 | 1,242 | 0.3 | - |
Current WHO stage | ||||
 I/II | 464 | 1,045 | 44.4 | (41.4–47.4) |
 III/IV | 581 | 1,045 | 55.6 | (52.6–58.6) |
 Missing | 197 | 1,242 | 15.9 | - |
Current CD4 cell counta | ||||
  ≤ 50 | 26 | 349 | 7.5 | (5.1–10.7) |
 51–200 | 75 | 349 | 21.5 | (17.5–26.1) |
 201–350 | 75 | 349 | 21.5 | (17.5–26.1) |
 351–500 | 78 | 349 | 22.4 | (18.3–27.0) |
  > 500 | 95 | 349 | 27.2 | (22.8–32.2) |
 Missing | 893 | 1,242 | 71.9 | - |
  Median (IQR) |  | 349 | 348 (174–510) |  |